Our results showed that the PPARγ, C/EBPα, FABP4, and FAS genes were significantly downregulated in CA-treated mice (Figure 8), suggesting that CA may have the ability to reduce lipid accumulation and further alleviate obesity by restraining adipogenesis and lipid synthesis. Here, CEBPA is linked to obesity disorder.